Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02014740
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- University of Miami
- Registry
-
NCT02014740
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02014740. Randomized; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2017-03 (actual). Results posted on 2018-03-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Condition
- Overweight
- Condition
- Obesity
- Intervention (Drug)
- Liraglutide
- Intervention (Drug)
- Metformin
- Lead sponsor
- University of Miami
Record details
- Record id
cardio:ct-nct02014740- Content hash
8f6d6843e6be53c9a8d9dd810a72b0c8ed07e65c67630c371b016f7f4d696e53